Velarion Records
Free. Unsubscribe any time.

Fulcrum Therapeutics, Inc. (FULC)

Fulcrum Therapeutics, Inc. filed 5 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 5 transactions and 66,452 shares. None carries the SEC's AFF10B5ONE flag; all 5 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Fulcrum Therapeutics, Inc. 5

Adoption dates in Fulcrum Therapeutics, Inc. 3

Results prints in Fulcrum Therapeutics, Inc. 0

Trades before a print in Fulcrum Therapeutics, Inc. 0

Interval to Fulcrum Therapeutics, Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Fulcrum Therapeutics, Inc. states

Filing text: “10b5-1 trading plan adopted by the reporting person on August 1, 2025”

Sources: SEC EDGAR full-text search and the SEC submissions API.